Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Martin Witzenrath and Stefan Hippenstiel.
Martin Witzenrath
Connection Strength
0.456
Stefan Hippenstiel
  1. A time-resolved proteomic and prognostic map of COVID-19. Cell Syst. 2021 08 18; 12(8):780-794.e7.
    View in: PubMed
    Score: 0.059
  2. Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study. Infection. 2021 Aug; 49(4):703-714.
    View in: PubMed
    Score: 0.059
  3. Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure. Eur Respir J. 2021 03; 57(3).
    View in: PubMed
    Score: 0.058
  4. A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model. Cell. 2020 11 12; 183(4):1058-1069.e19.
    View in: PubMed
    Score: 0.057
  5. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell. 2020 09 17; 182(6):1419-1440.e23.
    View in: PubMed
    Score: 0.056
  6. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. 2020 11; 587(7833):270-274.
    View in: PubMed
    Score: 0.056
  7. Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19). Infection. 2020 Aug; 48(4):619-626.
    View in: PubMed
    Score: 0.055
  8. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection. Cell Syst. 2020 07 22; 11(1):11-24.e4.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.